Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Saudi Arabia

The facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi Arabia

Co-Diagnostics, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that CoMira Diagnostics (CoMira), the Company's joint venture (JV) with Arabian Eagle Manufacturing in the Kingdom of Saudi Arabia (KSA), has secured an industrial land allocation in Sudair Industrial City located in the Riyadh region, one of Saudi Arabia's leading industrial hubs, following approval by the Saudi Authority for Industrial Cities and Technology Zones (MODON). The final lease agreement is expected to be executed upon completion of site infrastructure requirements.

Sudair Industrial City, developed and managed by MODON, plays a central role in the KSA's Vision 2030 strategy to diversify the economy and strengthen local manufacturing capabilities.

"We believe that a manufacturing facility in Sudair Industrial City could play an important role in achieving our JV's mission to localise advanced diagnostic technologies within the KSA, including the Co-Dx PCR platform, and is expected to support our international expansion objectives across the Middle East and Northern Africa," remarked Dwight Egan, CEO of Co-Diagnostics.

The allocated site is intended to support, subject to further development activities and approvals, the development of a state-of-the-art manufacturing facility dedicated to molecular diagnostic instruments and assays, which would be designed and built to meet CoMira's specific production and regulatory requirements.

The project aligns with Saudi Arabia's increasing emphasis on local content and domestic production, particularly in government procurement programs where in-country manufacturing may be a key differentiator.

Ihssan Rjoob, CEO of CoMira Diagnostics, commented, "Securing our presence in Sudair Industrial City represents a foundational milestone for CoMira. This step reflects our long-term commitment to localising advanced molecular diagnostics in Saudi Arabia, contributing to the Kingdom's Vision 2030 objectives, and advancing CoMira's mission to establish a fully integrated molecular diagnostics platform in Saudi Arabia."